Synthesis and biological properties of novel brefeldin A analogues

Journal of Medicinal Chemistry

Volumn 56, Issue 14, 2013, Pages 5872-5884

  Seehafer, Kai ^a   Rominger, Frank ^a   Helmchen, Günter ^a   Langhans, Markus ^a   Robinson, David G ^a   Özata, Başak ^a   Brügger, Britta ^a   Strating, Jeroen R P M ^b   Van Kuppeveld, Frank J M ^b   Klein, Christian D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; ANTINEOPLASTIC AGENT; BREFELDIN A; ETHYL NOR BREFELDIN A; PEPTIDES AND PROTEINS; PROTEIN SEC7; TRIFLUOROMETHYL NOR BREFELDIN A; UNCLASSIFIED DRUG; VINYL NOR BREFELDIN A;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROBORATION; MOLECULAR DOCKING; SUZUKI REACTION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BREFELDIN A; ENTEROVIRUS B, HUMAN; GOLGI APPARATUS; HELA CELLS; HUMANS; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 84880886509     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400615g     Document Type: Article

References (82)

1. Singleton, V. L.; Bohonos, N.; Ullstrup, A. J. Decumbin. A new compound from a species of Penicillium Nature 1958, 181, 1072-1073
2. Sunagawa, M.; Ohta, T.; Nozoe, S. Biosynthesis of Brefeldin A. Introduction of Oxygen at the C-7 Position J. Antibiot. 1983, 36, 25-29
3. Yamamoto, Y.; Hori, A.; Hutchinson, C. R. Biosynthesis of Macrolide Antibiotics. 6. Late Steps in Brefeldin A Biosynthesis J. Am. Chem. Soc. 1985, 107, 2471-2474
4. Härri, E.; Loeffler, W.; Sigg, H. P.; Stähelin, H.; Tamm, C. Über die Isolierung neuer Stoffwechselprodukte aus Penicillium brefeldianum DODGE Helv. Chim. Acta 1963, 46, 1235-1243
5. Tamura, G.; Ando, K.; Suzuki, S.; Takatsuki, A.; Arima, K. Antiviral activity of Brefeldin A and Verrucarin A J. Antibiot. 1968, 21, 160-161
6. Bačíková, D.; Betina, V.; Nemec, P. Antinematodal activity of the antibiotic cyanein Naturwissenschaften 1964, 51, 445
7. Betina, V.; Montagnier, L. Action of cyanein on the synthesis of nucleic acids and proteins in animal cells and bacterial protoplasts Bull. Soc. Chim. Biol. 1966, 48, 194-198
8. Betina, V.; Horáková, K.; Baráth, Z. Anti-HeLa cell effect of cyanein Naturwissenschaften 1962, 49, 241
9. DTP Data; Division of Cancer Treatment and Diagnostics, NCI/NIH; http://dtp.nci.nih.gov/docs/dtp-search.html (NSC for 1, 56310; NSC for 15-nor-brefeldin A, 746708).
10. Shao, R. G.; Shimizu, T.; Pommier, Y. Brefeldin A is a Potent Inducer of Apoptosis in Human Cancer Cells Independently of p53 Exp. Cell. Res. 1996, 227, 190-196
11. Nojiri, H.; Hori, H.; Nojima, S. Induction of Cell Differentiation and Apoptosis into Human Malignant Tumor Cell Lines by Drugs Affecting Ganglioside Biosynthesis Glycoconjugate J. 1995, 12, 459
12. Nojiri, H.; Manya, H.; Isono, H.; Yamana, H.; Nojima, S. Induction of terminal differentiation and apoptosis in human colonic carcinoma cells by brefeldin A, a drug affecting ganglioside biosynthesis FEBS Lett. 1999, 453, 140-144
13. Fujiwara, T.; Oda, K.; Yokota, S.; Takatsuki, A.; Ikehara, Y. Brefeldin A Causes Disassembly of the Golgi Complex and Accumulation of Secretory Proteins in the Endoplasmic Reticulum J. Biol. Chem. 1988, 263, 18545-18552
14. Lippincott-Schwartz, J.; Yuan, L. C.; Bonifacino, J. S.; Klausner, R. D. Rapid Redistribution of Golgi Proteins into the ER in Cells Treated with Brefeldin A: Evidence for Membrane Cycling from Golgi to ER Cell 1989, 56, 801-813
15. Nebenführ, A.; Madison, S. L. Live-Cell Imaging of Dual-Labeled Golgi Stacks in Tobacco BY-2 Cells Reveals Similar Behaviors for Different Cisternae during Movement and Brefeldin A Treatment Mol. Plant 2011, 4, 896-908
16. Nebenführ, A.; Ritzenthaler, C.; Robinson, D. G. Brefeldin A: Deciphering an Enigmatic Inhibitor of Secretion Plant Physiol. 2002, 130, 1102-1108 and literature cited therein
17. Donaldson, J. G.; Finazzi, D.; Klausner, R. D. Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein Nature 1992, 360, 350-352
18. Helms, J. B.; Rothman, J. E. Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF Nature 1992, 360, 350-352
19. Rothman, J. E.; Wieland, F. T. Protein Sorting by Transport Vesicles Science 1996, 272, 227-234
20. Brügger, B.; Wieland, F. T. Mechanismen der COPI-Vesikelbiogenese Biospektrum 2004, 1, 30-33
21. Bonifacino, J. S.; Lippincott-Schwartz, J. Coat proteins: shaping membrane transport Nature Rev. Mol. Cell Biol. 2003, 4, 409-414
22. Renault, L.; Guibert, B.; Cherfils, J. Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor Nature 2003, 426, 525-530
23. Mossessova, E.; Corpina, R. A.; Goldberg, J. Crystal Structure of ARF1·Sec7 Complexed with Brefeldin A and Its Implications for the Guanine Nucleotide Exchange Mechanism Mol. Cell 2003, 12, 1403-1411
24. Phillips, L. R.; Supko, J. G.; Malspeis, L. Analysis of Brefeldin A in Plasma by Gas Chromatography with Electron Capture Detection Anal. Biochem. 1993, 211, 16-22
25. For more information see: Developmental Therapeutics Program; Division of Cancer Treatment and Diagnostics, NCI/NIH; http://dtp.nci.nih.gov.
26. Zhu, J.-W.; Hori, H.; Nojiri, H.; Tsukuda, T.; Taira, Z. Synthesis And Activity Of Brefeldin A Analogs As Inducers Of Cancer Cell Differentiation And Apoptosis Bioorg. Med. Chem. Lett. 1997, 7, 139-144
27. Argade, A. B.; Devraj, R.; Vroman, J. A.; Haugwitz, R. D.; Hollingshead, M.; Cushman, M. Design and Synthesis of Brefeldin A Sulfide Derivatives as Prodrug Candidates with Enhanced Aqueous Solubilities J. Med. Chem. 1998, 41, 3337-3346
28. Argade, A. B.; Haugwitz, R. D.; Devraj, R.; Kozlowski, J.; Fanwick, P. E.; Cushman, M. Highly Efficient Diastereoselective Michael Addition of Various Thiols to (+)-Brefeldin A J. Org. Chem. 1998, 63, 273-278
29. Fox, B. M.; Vroman, J. A.; Fanwick, P. E.; Cushman, M. Preparation and Evaluation of Sulfide Derivatives of the Antibiotic Brefeldin A as Potential Prodrug Candidates with Enhanced Aqueous Solubilities J. Med. Chem. 2001, 44, 3915-3924
30. Anadu, N. O.; Davisson, V. J.; Cushman, M. Synthesis and Anticancer Activity of Brefeldin A Ester Derivatives J. Med. Chem. 2006, 49, 3897-3905
31. Ref 17g. For brefeldin analogues derived by total synthesis see
32. Förster, S.; Persch, E.; Tverskoy, O.; Rominger, F.; Helmchen, G.; Klein, C.; Gönen, B.; Brügger, B. Syntheses and Biological Properties of Brefeldin Analogues Eur. J. Org. Chem. 2011, 878-891
33. Hübscher, T.; Helmchen, G. Enantioselective Formal Synthesis of Brefeldin A and Analogues via Anionic Cyclization of an Alkenyl Epoxide Synlett 2006, 1323-1326
34. Förster, S.; Helmchen, G. Stereoselective Synthesis of a Lactam Analogue of Brefeldin C Synlett 2008, 831-836
35. Paek, S.-M.; Seo, S.-Y.; Min, K.-H.; Shin, D. M.; Chung, Y. K.; Suh, Y.-G. Synthesis of Lactam Analogue of 4-epi-Brefeldin A Heterocycles 2007, 71, 1059-1066
36. Gao, J.; Huang, Y.-X.; Wu, Y. Enantioselective total synthesis of 13- O -brefeldin A Tetrahedron 2008, 64, 11105-11109
37. Archambaud, S.; Aphecetche-Julienne, K.; Guingant, A. A New Total Synthesis of (+)-Brefeldin C Synlett 2005, 139-143
38. Archambaud, S.; Legrand, F.; Aphecetche-Julienne, K.; Collet, S.; Guingant, A.; Evain, M. Total Synthesis of (+)-Brefeldin C, (+)-nor-Me Brefeldin A and (+)-4-epi-nor-Me Brefeldin A Eur. J. Org. Chem. 2010, 1364-1380
39. Inai, M.; Nishii, T.; Mukoujima, S.; Esumi, T.; Kaku, H.; Tominaga, K.; Abe, H.; Horikawa, M.; Tsunoda, T. Total Synthesis of (+)-Brefeldin C Utilizing Aza-Claisen Rearrangement Synlett 2011, 1459-1461
40. Kozikowski, A. P.; Shum, P. W.; Basu, A.; Lazo, J. S. Synthesis of structural analogues of lyngbyatoxin A and their evaluation as activators of protein kinase C J. Med. Chem. 1991, 34, 2420-2430
41. Soai, K.; Niwa, S. Enantioselective Addition of Organozinc Reagents to Aldehydes Chem. Rev. 1992, 92, 833-856
42. Pu, L.; Yu, H.-B. Catalytic Asymmetric Organozinc Additions to Carbonyl Compounds Chem. Rev. 2001, 101, 757-824
43. Soai, K.; Yokoyama, S.; Ebihara, K.; Hayasaka, T. A New Chiral Catalyst for the Highly Enantioselective Addition of Dialkylzinc Reagents to Aliphatic Aldehydes J. Chem. Soc., Chem. Commun. 1987, 1690-1691
44. 2 Synthesis Synthesis 1999, 1209-1215
45. Haynes, R. K.; Lam, W. W.-L.; Yeung, L.-L.; Williams, I. D.; Ridley, A. C.; Starling, S. M.; Vonwiller, S. C.; Hambley, T. W.; Lelandais, P. Highly diastereoselective conjugate addition of lithiated γ-crotonolactone (but-2-en-4-olide) to cyclic enones to give syn-adducts: application to a brefeldin synthesis J. Org. Chem. 1997, 62, 4552-4553
46. Trost, B. M.; Crawley, M. L. A "chiral aldehyde" equivalent as a building block towards biologically active targets Chem.-Eur. J. 2004, 10, 2237-2252
47. Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. A rapid esterification by means of mixed anhydride and its application to large-ring lactonization Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993
48. Williams, D. R.; Jass, P. A.; Tse, H.-L. A.; Gaston, R. D. Total Synthesis of (+)-breynolide J. Am. Chem. Soc. 1990, 112, 4552
49. Müller, K.; Faeh, C.; Diederich, F. Fluorine in pharamceuticals: looking beyond intuition Science 2007, 317, 1881-1886
50. Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Fluorine in medicinal chemistry Chem. Soc. Rev. 2008, 37, 320-330
51. O'Hagan, D. Understanding organofluorine chemistry. An introduction to the C-F bond Chem. Soc. Rev. 2008, 37, 308-319
52. 3- substituierten Organyl(chlor)silane Tetrahedron Lett. 1984, 25, 2195-2198
53. 3). A trifluormethide equivalent J. Am. Chem. Soc. 1989, 111, 393-395
54. Gärtner, M.; Mader, S.; Seehafer, K.; Helmchen, G. Enantio- and regioselective iridium-catalyzed allylic hydroxylation J. Am. Chem. Soc. 2011, 133, 2072-2075
55. Spiess, S.; Welter, C.; Franck, G.; Taquet, J.-P.; Helmchen, G. Iridium-catalyzed asymmetric allylic substitutions-very high regioselectivity and air stability with a catalyst derived from dibenzo[ a, e ]cyclooctatetraene and a phosphoramidite Angew. Chem., Int. Ed. 2008, 47, 7652-7655
56. Raskatov, J. A.; Spiess, S.; Gnamm, C.; Brödner, K.; Rominger, F.; Helmchen, G. Ir-catalysed asymmetric allylic substitutions with cyclometalated (phosphoramidite)Ir complexes-resting states, catalytically active (π-allyl)Ir complexes and computational exploration Chem.-Eur. J. 2010, 6601-6615
57. Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Catalytic asymmetric dihydroxylation Chem. Rev. 1994, 94, 2483-2547
58. Lohray, B. B. Recent advances in the asymmetric dihydroxylation of alkenes Tetrahedron: Asymmetry 1992, 3, 1317-1349
59. Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. The osmium-catalyzed asymmetric dihydroxylation: a new ligand class and a process improvement J. Org. Chem. 1992, 57, 2768-2771
60. Greene, A. E.; Le Drian, C.; Crabbé, P. An efficient total synthesis of (±)-Brefeldin-A J. Am. Chem. Soc. 1980, 102, 7583-7584
61. Review: Tsuji, J. Synthetic applications of the palladium-catalyzed oxidation of olefins to ketones Synthesis 1984, 5, 369-384
62. Langhans, M.; Förster, S.; Helmchen, G.; Robinson, D. G. Differential effects of the brefeldin A analogue (6R)-hydroxy-brefeldin A in tobacco and Arabidopsis J. Exp. Bot. 2011, 62, 2949-2957
63. Irurzun, A.; Perez, L.; Carrasco, L. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A Virology 1992, 191, 166-175
64. Maynell, L. A.; Kirkegaard, K.; Klymkowsky, M. W. Inhibition of Poliovirus RNA Synthesis by Brefeldin A J. Virol. 1992, 66, 1985-1994
65. Hsu, N.-Y.; Ilnytska, O.; Belov, G.; Santiana, M.; Chen, Y.-H.; Takvorian, P. M.; Pau, C.; van der Schaar, H.; Kaushik-Basu, N.; Balla, T.; Cameron, C. E.; Ehrenfeld, E.; van Kuppeveld, F. J. M.; Altan-Bonnet, N. Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication Cell 2010, 141, 799-811
66. Nagy, P. D.; Pogany, J. The dependence of viral RNA replication on co-opted host factors Nature Rev. Microbiol. 2011, 10, 137-149
67. Wessels, E.; Duijsings, D.; Niu, T.-K.; Neumann, S.; Oorschot, V. M.; de Lange, F.; Lanke, K. H. W.; Klumperman, J.; Henke, A.; Jackson, C. L.; Melchers, W. J. G.; van Kuppeveld, F. J. M. A Viral Protein that Blocks Arf1-Mediated COP-I Assembly by Inhibiting the Guanine Nucleotide Exchange Factor GBF1 Dev. Cell 2006, 11, 191-201
68. Belov, G. A.; Altan-Bonnet, N.; Kovtunovych, G.; Jackson, C. L.; Lippincott-Schwartz, J.; Ehrenfeld, E. Hijacking Components of the Cellular Secretory Pathway for Replication of Poliovirus RNA J. Virol. 2007, 81, 558-567
69. Lanke, K. H. W.; van der Schaar, H. M.; Belov, G. A.; Feng, Q.; Duijsings, D.; Jackson, C. L.; Ehrenfeld, E.; van Kuppeveld, F. J. M. GBF1, a Guanine Nucleotide Exchange Factor for Arf, Is Crucial for Coxsackievirus B3 RNA Replication J. Virol. 2009, 83, 11940-11949
70. Mansour, S. J.; Skaug, J.; Zhao, X.-H.; Giordano, J.; Scherer, S. W.; Melançon, P. p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7 domain is targeted by the drug brefeldin A Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 7968-7973
71. Peyroche, A.; Antonny, B.; Robineau, S.; Acker, J.; Cherfils, J.; Jackson, C. L. Brefeldin A Acts to Stabilize an Abortive ARF-GDP-Sec7 Domain Protein Complex: Involvement of Specific Residues of the Sec7 Domain Mol. Cell 1999, 3, 275-285
72. MacroModel is a product of Schrödinger, LLC; for detailed information see: MacroModel; Schrödinger, LLC: New York, 2013; http://www.schrodinger.com/products/14/11.
73. Chang, G.; Guida, W. C.; Still, W. C. An Internal Coordinate Monte Carlo Method for Searching Conformational Space J. Am. Chem. Soc. 1989, 111, 4379-4386
74. 2O was used as solvent model.
75. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and Validation of a Genetic Algorithm for Flexible Docking J. Mol. Biol. 1997, 267, 727-748
76. For more information see: GOLD 5.1; Cambridge Crystallographic Data Centre: Cambridge, UK; http://www.ccdc.cam.ac.uk/products/life-sciences/gold.
77. Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera-A Visualization System for Exploratory Research and Analysis J. Comput. Chem. 2004, 25, 1605-1612
78. For more information see: UCSF Chimera, An Extensible Molecular Modeling System; University of California, San Francisco: San Francisco, CA; http://www.cgl.ucsf.edu/chimera.
79. Biological Macromolecular Resource; RCSB Protein Data Bank; http://www.rcsb.org/pdb/home/home.do.
80. +-ATPase Activity Is Required for Endocytic and Secretory Trafficking in Arabidopsis Plant Cell 2006, 18, 715-730
81. Murashige, T.; Skoog, F. A. A Revised Medium for Rapid Growth and Bio Assays with Tobacco Tissue Cultures Physiol. Plant. 1962, 15, 473-497
82. Rutz, C.; Satoh, A.; Ronchi, P.; Brügger, B.; Warren, G.; Wieland, F. T. Following the Fate In Vivo of COPI Vesicles Generated In Vitro Traffic 2009, 10, 994-1005